Form 4: Surgery Partners Executive Sells Shares to Cover Tax Obligations

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, sold 612 shares of common stock on March 14, 2025, to cover tax obligations related to vesting restricted stock.

Summary

• On March 14, 2025, Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, sold 612 shares of the company's common stock.
• The sale was executed at a weighted average price of $23.94 per share.
• The transaction was conducted to satisfy tax withholding obligations related to the vesting of restricted stock on March 11, 2025.
• Following the transaction, Baldock directly owns 236,047 shares of Surgery Partners' common stock.

Sentiment

Score: 5

Explanation: The document is neutral, simply reporting a routine stock sale for tax purposes. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This particular filing indicates a sale of shares to cover tax obligations, which is a common practice.

Stakeholder Impact

• The sale is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors, as it is a relatively small transaction by an individual executive to cover personal tax obligations.

Key Dates